House Committee Advances Bill to Tighten Medicare DME Fraud Rules
/ 1 min read
Table of Contents
The House Committee on Ways and Means voted 25-19 to report the DME Scammer Prevention Act of 2026 in the nature of a substitute. This means the committee has finished its work on the bill and is sending it to the full House floor for a vote. The bill is not law. It has not been passed by the full House or the Senate, and it has not been signed by the President.
Why it matters: This is a procedural step in the legislative process, not a change in current law. It signals that the committee intends to push for stricter oversight in a sector where Medicare fraud is a known issue. Until the bill is enacted, current rules for DME billing and verification remain in effect.
Who it affects
- Durable medical equipment suppliers and distributors
The source is the official Congressional Record on Congress.gov, which tracks committee actions; readers should check the full bill text to understand specific compliance requirements before assuming any changes to their business or benefits.
Agency: House
Source: Congress.gov — read the official document